http://orcid.org/0000-0002-6652-1891
Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tanvir F Kabir, Charles A Kunos, John L Villano & Aman Chauhan. (2020) Immunotherapy for Medulloblastoma: Current Perspectives. ImmunoTargets and Therapy 9, pages 57-77.
Read now
Read now
Articles from other publishers (58)
Xing-Guo Li & Jer-Yen Yang. 2023. Tumor Microenvironment - New Insights. Tumor Microenvironment - New Insights.
Jack Hedberg, Adam Studebaker, Luke Smith, Chun-Yu Chen, Jesse J. Westfall, Maren Cam, Amy Gross, Ilse Hernandez-Aguirre, Alexia Martin, Doyeon Kim, Ravi Dhital, Yeaseul Kim, Ryan D. Roberts, Timothy P. Cripe, Elaine R. Mardis, Kevin A. Cassady, Jeffrey Leonard & Katherine E. Miller. (2023) Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution. Molecular Therapy - Oncolytics 30, pages 39-55.
Crossref
Crossref
Marwa Ismail, Stephen Craig, Raheel Ahmed, Peter de Blank & Pallavi Tiwari. (2023) Opportunities and Advances in Radiomics and Radiogenomics for Pediatric Medulloblastoma Tumors. Diagnostics 13:17, pages 2727.
Crossref
Crossref
W. de Koning, F. F. Feenstra, F. G. J. Calkoen, J. van der Lugt, L. A. Kester & D. A. M. Mustafa. (2023) Characterizing the tumor immune microenvironment of ependymomas using targeted gene expression profiles and RNA sequencing. Cancer Immunology, Immunotherapy 72:8, pages 2659-2670.
Crossref
Crossref
Julian S. Rechberger, Stephanie A. Toll, Wouter J. F. Vanbilloen, David J. Daniels & Soumen Khatua. (2023) Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and Treatment. Diagnostics 13:14, pages 2398.
Crossref
Crossref
Shreya Budhiraja, Hinda Najem, Shashwat Tripathi, Nitin R. Wadhawani, Craig Horbinski, Matthew McCord, Alicia C. Lenzen, Amy B. Heimberger & Michael DeCuypere. (2023) Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review. Cancers 15:14, pages 3655.
Crossref
Crossref
Andrew Rodriguez, Carlos Kamiya-Matsuoka & Nazanin K. Majd. (2023) The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors. Current Oncology 30:6, pages 5279-5298.
Crossref
Crossref
Betty Yao, Alberto Delaidelli, Hannes Vogel & Poul H. Sorensen. (2023) Pediatric Brain Tumours: Lessons from the Immune Microenvironment. Current Oncology 30:5, pages 5024-5046.
Crossref
Crossref
Michael Y Schakelaar, Matthijs Monnikhof, Sandra Crnko, Emma W Pijnappel, Jan Meeldijk, Toine ten Broeke & Niels Bovenschen. (2023) Cellular immunotherapy for medulloblastoma. Neuro-Oncology 25:4, pages 617-627.
Crossref
Crossref
YingGang Zou, Ying Xu, XiaoChen Chen & Lianwen Zheng. (2023) Advances in the application of immune checkpoint inhibitors in gynecological tumors. International Immunopharmacology 117, pages 109774.
Crossref
Crossref
Francesca Gorini, Marco Miceli, Pasqualino de Antonellis, Stefano Amente, Massimo Zollo & Veronica Ferrucci. (2023) Epigenetics and immune cells in medulloblastoma. Frontiers in Genetics 14.
Crossref
Crossref
Rui Ferreira Marques, Daniel Antunes Moreno, Luciane da Silva, Leticia Ferro Leal, Flávia Escremim de Paula, Iara Santana, Gustavo Teixeira, Fabiano Saggioro, Luciano Neder, Carlos Almeida Junior, Bruna Mançano & Rui Manuel Reis. (2023) Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets. Frontiers in Immunology 14.
Crossref
Crossref
Dagoberto Estevez-Ordonez, Sam E. Gary, Travis J. Atchley, Pedram D. Maleknia, Jordan A. George, Nicholas M.B. Laskay, Evan G. Gross, Rishi K. Devulapalli & James M. Johnston. (2023) Immunotherapy for Pediatric Brain and Spine Tumors: Current State and Future Directions. Pediatric Neurosurgery 58:5, pages 313-336.
Crossref
Crossref
Margot A. Lazow, Joshua D. Palmer, Maryam Fouladi & Ralph Salloum. (2022) Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics 19:6, pages 1733-1751.
Crossref
Crossref
Jinyi Chen, Zhuang Kang, Shenglan Li, Can Wang, Xiaohong Zheng, Zehao Cai, Lexin Pan, Feng Chen & Wenbin Li. (2022) Molecular profile reveals immune-associated markers of medulloblastoma for different subtypes. Frontiers in Immunology 13.
Crossref
Crossref
S. Li, G. C. Poolen, L. C. van Vliet, J. G. Schipper, R. Broekhuizen, M. Monnikhof, W. Van Hecke, J. F. Vermeulen & N. Bovenschen. (2022) Pediatric medulloblastoma express immune checkpoint B7-H3. Clinical and Translational Oncology 24:6, pages 1204-1208.
Crossref
Crossref
Iurii Petrov & Andrey Alexeyenko. (2022) Individualized discovery of rare cancer drivers in global network context. eLife 11.
Crossref
Crossref
Yongsheng Li, Sicong Xu, Dahua Xu, Tao Pan, Jing Guo, Shuo Gu, Qiuyu Lin, Xia Li, Kongning Li & Wei Xiang. (2022) Pediatric Pan-Central Nervous System Tumor Methylome Analyses Reveal Immune-Related LncRNAs. Frontiers in Immunology 13.
Crossref
Crossref
Tanja Eisemann & Robert J. Wechsler-Reya. (2022) Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma. Genes & Development 36:9-10, pages 514-532.
Crossref
Crossref
Jacob S. Rozowsky, Joyce I. Meesters-Ensing, Julie A. S. Lammers, Muriël L. Belle, Stefan Nierkens, Mariëtte E. G. Kranendonk, Lennart A. Kester, Friso G. Calkoen & Jasper van der Lugt. (2022) A Toolkit for Profiling the Immune Landscape of Pediatric Central Nervous System Malignancies. Frontiers in Immunology 13.
Crossref
Crossref
Adel Naimi, Rebar N. Mohammed, Ahmed Raji, Supat Chupradit, Alexei Valerievich Yumashev, Wanich Suksatan, Mohammed Nader Shalaby, Lakshmi Thangavelu, Siavash Kamrava, Navid Shomali, Armin D. Sohrabi, Ali Adili, Ali Noroozi-Aghideh & Ehsan Razeghian. (2022) Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell Communication and Signaling 20:1.
Crossref
Crossref
Marieke Gringmuth, Jenny Walther, Sebastian Greiser, Magali Toussaint, Benjamin Schwalm, Marcel Kool, Rolf-Dieter Kortmann, Annegret Glasow & Ina Patties. (2022) Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir. International Journal of Molecular Sciences 23:7, pages 3815.
Crossref
Crossref
Zahra Abbas, Courtney George, Mathew Ancliffe, Meegan Howlett, Anya C. Jones, Mani Kuchibhotla, Robert J. Wechsler-Reya, Nicholas G. Gottardo & Raelene Endersby. (2022) Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets. Frontiers in Immunology 13.
Crossref
Crossref
Ombretta Melaiu, Valeria Lucarini, Roberto Giovannoni, Doriana Fruci & Federica Gemignani. (2022) News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors. Seminars in Cancer Biology 79, pages 18-43.
Crossref
Crossref
David R. Ghasemi, Gudrun Fleischhack, Till Milde & Kristian W. Pajtler. (2022) The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma. Cancers 14:3, pages 679.
Crossref
Crossref
Somayeh Vafaei, Angelina O. Zekiy, Ramadhan Ado Khanamir, Burhan Abdullah Zaman, Arman Ghayourvahdat, Hannaneh Azimizonuzi & Majid Zamani. (2022) Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier. Cancer Cell International 22:1.
Crossref
Crossref
Sampurna Chatterjee. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
11
.
Rebecca M. Hill, Sabine L. A. Plasschaert, Beate Timmermann, Christelle Dufour, Kristian Aquilina, Shivaram Avula, Laura Donovan, Maarten Lequin, Torsten Pietsch, Ulrich Thomale, Stephan Tippelt, Pieter Wesseling, Stefan Rutkowski, Steven C. Clifford, Stefan M. Pfister, Simon Bailey & Gudrun Fleischhack. (2021) Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment. Cancers 14:1, pages 126.
Crossref
Crossref
Lourdes Alvarez-Arellano, Pilar Eguía-Aguilar, Patricia Piña-Sánchez, Nadia González-García, Alam Palma-Guzman, Mario Perezpeña-Diazconti & Carmen Maldonado-Bernal. (2021) High expression of Toll-like receptor 7 is a survival factor in pediatric medulloblastoma. Child's Nervous System 37:12, pages 3743-3752.
Crossref
Crossref
Jin Zhang & Tianyou Wang. (2021) Immune cell landscape and immunotherapy of medulloblastoma. Pediatric Investigation 5:4, pages 299-309.
Crossref
Crossref
Claudia Paret, Nadine Lehmann, Hannah Bender, Maximilian Sprang, Clemens J. Sommer, Denis Cana, Larissa Seidmann, Arthur Wingerter, Marie A. Neu, Khalifa El Malki, Francesca Alt, Lea Roth, Federico Marini, Malte Ottenhausen, Martin Glaser, Markus Knuf, Alexandra Russo & Joerg Faber. (2021) Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1. Cancers 13:22, pages 5838.
Crossref
Crossref
Silpa Gampala & Jer-Yen Yang. (2021) Hedgehog Pathway Inhibitors against Tumor Microenvironment. Cells 10:11, pages 3135.
Crossref
Crossref
Viktoria Melcher & Kornelius Kerl. (2021) The Growing Relevance of Immunoregulation in Pediatric Brain Tumors. Cancers 13:22, pages 5601.
Crossref
Crossref
Marije J. Voskamp, Shuang Li, Kim R. van Daalen, Sandra Crnko, Toine ten Broeke & Niels Bovenschen. (2021) Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives. Cancers 13:21, pages 5387.
Crossref
Crossref
Zahraa F. Audi, Zahraa Saker, Mahdi Rizk, Hayat Harati, Youssef Fares, Hisham F. Bahmad & Sanaa M. Nabha. (2021) Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy. Current Treatment Options in Oncology 22:9.
Crossref
Crossref
Shobha Mandal, Bishnu Singh, Sumit Gami, Sunil Shah & Joyson Poulose. (2021) Medulloblastoma in an Adult Female Patient: A Rare Presentation. Cureus.
Crossref
Crossref
Sumana Shrestha, Alaide Morcavallo, Chiara Gorrini & Louis Chesler. (2021) Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead. Frontiers in Oncology 11.
Crossref
Crossref
Mélanie Gauthier, Caroline Laroye, Danièle Bensoussan, Cédric Boura & Véronique Decot. (2021) Natural Killer cells and monoclonal antibodies: Two partners for successful antibody dependent cytotoxicity against tumor cells. Critical Reviews in Oncology/Hematology 160, pages 103261.
Crossref
Crossref
Jesus Garcia-Lopez, Rahul Kumar, Kyle S. Smith & Paul A. Northcott. (2021) Deconstructing Sonic Hedgehog Medulloblastoma: Molecular Subtypes, Drivers, and Beyond. Trends in Genetics 37:3, pages 235-250.
Crossref
Crossref
Yuduo Guo, Shenglun Li, Peng Huang, Hongwei Zhang & Chunjiang Yu. (2021) Development of a prognostic model based on an immunogenomic landscape analysis of medulloblastoma. Bioscience Reports 41:1.
Crossref
Crossref
I-Li Tan, Raquel Duque Nascimento Arifa, Harikrishna Rallapalli, Veronika Kana, Zhimin Lao, Reeti Mayur Sanghrajka, N. Sumru Bayin, Antoine Tanne, Alexandre Wojcinski, Andrey Korshunov, Nina Bhardwaj, Miriam Merad, Daniel H. Turnbull, Juan J. Lafaille & Alexandra L. Joyner. (2020) CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model. Oncogene 40:2, pages 396-407.
Crossref
Crossref
Deepak Upreti, David Bakhshinyan, Darin Bloemberg, Parvez Vora, Chitra Venugopal & Sheila K. Singh. (2020) Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors. Frontiers in Immunology 11.
Crossref
Crossref
Yura Grabovska, Alan Mackay, Patricia O’Hare, Stephen Crosier, Martina Finetti, Edward C. Schwalbe, Jessica C. Pickles, Amy R. Fairchild, Aimee Avery, Julia Cockle, Rebecca Hill, Janet Lindsey, Debbie Hicks, Mark Kristiansen, Jane Chalker, John Anderson, Darren Hargrave, Thomas S. Jacques, Karin Straathof, Simon Bailey, Chris Jones, Steven C. Clifford & Daniel Williamson. (2020) Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity. Nature Communications 11:1.
Crossref
Crossref
Nadine Lehmann, Claudia Paret, Khalifa El Malki, Alexandra Russo, Marie Astrid Neu, Arthur Wingerter, Larissa Seidmann, Sebastian Foersch, Nicole Ziegler, Lea Roth, Nora Backes, Roger Sandhoff & Joerg Faber. (2020) Tumor Lipids of Pediatric Papillary Renal Cell Carcinoma Stimulate Unconventional T Cells. Frontiers in Immunology 11.
Crossref
Crossref
John D. Patterson, Jeffrey C. Henson, Rebecca O. Breese, Kevin J. Bielamowicz & Analiz Rodriguez. (2020) CAR T Cell Therapy for Pediatric Brain Tumors. Frontiers in Oncology 10.
Crossref
Crossref
Rachael L. Terry, Deborah Meyran, David S. Ziegler, Michelle Haber, Paul G. Ekert, Joseph A. Trapani & Paul J. Neeson. (2020) Immune profiling of pediatric solid tumors. Journal of Clinical Investigation 130:7, pages 3391-3402.
Crossref
Crossref
Chang Li, Han Zou, Zujian Xiong, Yi Xiong, Danielle F. Miyagishima, Siyi Wanggou & Xuejun Li. (2020) Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma. Frontiers in Genetics 11.
Crossref
Crossref
Randy Van Ommeren, Livia Garzia, Borja L. Holgado, Vijay Ramaswamy & Michael D. Taylor. (2020) The molecular biology of medulloblastoma metastasis. Brain Pathology 30:3, pages 691-702.
Crossref
Crossref
Malte Mohme & Marian Christoph Neidert. (2020) Tumor-Specific T Cell Activation in Malignant Brain Tumors. Frontiers in Immunology 11.
Crossref
Crossref
Maojin Yao, P. Britten Ventura, Ying Jiang, Fausto J. Rodriguez, Lixin Wang, Justin S.A. Perry, Yibo Yang, Kelsey Wahl, Rowena B. Crittenden, Mariko L. Bennett, Lin Qi, Cong-Cong Gong, Xiao-Nan Li, Ben A. Barres, Timothy P. Bender, Kodi S. Ravichandran, Kevin A. Janes, Charles G. Eberhart & Hui Zong. (2020) Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth. Cell 180:3, pages 502-520.e19.
Crossref
Crossref
Hao Lian, Yi‐Peng Han, Yu‐Chao Zhang, Yang Zhao, Shan Yan, Qi‐Feng Li, Bao‐Cheng Wang, Jia‐Jia Wang, Wei Meng, Jian Yang, Qin‐Hua Wang, Wei‐Wei Mao & Jie Ma. (2019) Integrative analysis of gene expression and DNA methylation through one‐class logistic regression machine learning identifies stemness features in medulloblastoma. Molecular Oncology 13:10, pages 2227-2245.
Crossref
Crossref
Ke Li, Wen-chao Duan, Hai-biao Zhao, Li Wang, Wei-wei Wang, Yun-bo Zhan, Tao Sun, Feng-jiang Zhang, Bin Yu, Ya-hui Bai, Yan-min Wang, Yu-chen Ji, Jin-qiao Zhou, Xian-zhi Liu, Zhi-feng Zhang & Zhen-yu Zhang. (2019) Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma. Scientific Reports 9:1.
Crossref
Crossref
Franziska Blaeschke, Milan Cedric Paul, Martin Ulrich Schuhmann, Armin Rabsteyn, Christopher Schroeder, Nicolas Casadei, Jakob Matthes, Christopher Mohr, Ramin Lotfi, Beate Wagner, Theresa Kaeuferle, Judith Feucht, Semjon Willier, Rupert Handgretinger, Stefan StevanoviĆ, Peter Lang & Tobias Feuchtinger. (2019) Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy. Cytotherapy 21:9, pages 973-986.
Crossref
Crossref
Nazanin Majd & Marta Penas-Prado. (2019) Updates on Management of Adult Medulloblastoma. Current Treatment Options in Oncology 20:8.
Crossref
Crossref
Jakob Nikolas Kather, Christian Hörner, Cleo-Aron Weis, Thiha Aung, Christian Vokuhl, Christel Weiss, Monika Scheer, Alexander Marx & Katja Simon-Keller. (2019) CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma. Scientific Reports 9:1.
Crossref
Crossref
Hamza S. Gorsi, Denise M. Malicki, Valentin Barsan, Mark Tumblin, Lanipua Yeh-Nayre, Mehrzad Milburn, Jennifer D. Elster & John R. Crawford. (2019) Nivolumab in the Treatment of Recurrent or Refractory Pediatric Brain Tumors: A Single Institutional Experience. Journal of Pediatric Hematology/Oncology 41:4, pages e235-e241.
Crossref
Crossref
Eric K. Ring, G. Yancey Gillespie & Gregory K. Friedman. 2019. Immune Checkpoint Inhibitors in Cancer. Immune Checkpoint Inhibitors in Cancer
193
204
.
Yuuri Hashimoto, Marta Penas-Prado, Shouhao Zhou, Jun Wei, Soumen Khatua, Tiffany R. Hodges, Nader Sanai, Joanne Xiu, Zoran Gatalica, Lyndon Kim, Santosh Kesari, Ganesh Rao, David Spetzler & Amy Heimberger. (2018) Rethinking medulloblastoma from a targeted therapeutics perspective. Journal of Neuro-Oncology 139:3, pages 713-720.
Crossref
Crossref